Laser scanner test during breast cancer surgery
Part of Cancer clinical trials.
This trial tests a new laser scanner that helps doctors see if all cancer cells are removed during breast-conserving surgery, which might reduce the need for a second operation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman 18 years or older.
- You are scheduled for breast-conserving surgery for invasive or in-situ ductal or lobular breast cancer.
- You can read, understand, and sign a consent form in French.
- You are not scheduled for a full mastectomy or a tumor-adapted breast reduction.
- You are not pregnant or breastfeeding.
- You are not taking part in another study that could affect data collection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new imaging system that helps surgeons see if cancer cells remain after breast-conserving surgery. It may reduce the need for a second surgery by giving real-time feedback on the removed tissue.
This study tests a new scanner that helps doctors see if all the breast cancer was removed during surgery, right there in the operating room. It may help reduce the chance of needing a second surgery.
This trial tests a scanner that checks removed breast tissue during surgery to help surgeons remove all cancer the first time. If it works, fewer women may need a second operation.
This study compares two ways of checking during surgery to make sure all the cancer is removed: a new microscopic imaging technique versus the standard frozen section method. If you are having breast-conserving surgery, this may help ensure clear margins and reduce the need for a second surgery.
This study tests a new imaging tool that helps surgeons see cancer margins in real time during a lumpectomy, aiming to reduce the need for a second surgery. It is for women with early-stage breast cancer who are planning a lumpectomy.
This study tests a new imaging tool that helps surgeons see if any cancer cells are left behind during a lumpectomy. It may reduce the need for a second surgery.
Hear when a new Breast Cancer Invasive trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.